Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Tailored Antiplatelet Therapy Following PCI [Phase 4]
Phase 4 trial evaluating tailored antiplatelet therapy after PCI for coronary artery disease and acute coronary syndrome; results posted aft…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI [Phase 4]
A Phase 4 clinical trial is evaluating dual antithrombotic therapy with dabigatran and ticagrelor in patients with acute coronary syndrome a…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Implementing Precision Medicine Approaches to Guide Anti-platelet Selection [Phase 4]
Phase 4 trial update exploring precision medicine approaches to guide anti-platelet selection in acute coronary syndrome and MI settings.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial. [NA]
Clinical trial integration of natural history study and randomized trial in Acute Coronary Syndrome has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Reduce Bolus Injection of Bivalirudin [Phase 4]
A Phase 4 clinical trial update evaluating reduction of bolus injection of bivalirudin in acute coronary syndrome has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Pharmacodynamic Evaluation of Antiplatelet Effect of Swallowing Versus Chewing Ticagrelor in Patients With Acute Coronary Syndrome [Phase 4]
Phase 4 trial evaluating pharmacodynamic effects of swallowing versus chewing ticagrelor in acute coronary syndrome patients.
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: Investigating Fear Of Recurrence as a Modifiable Mechanism of Behavior Change [NA]
Clinical trial update on fear of recurrence as a modifiable mechanism of behavior change, completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms [NA]
Clinical trial update on mindfulness-based cognitive therapy delivered via group videoconferencing for ACS patients with elevated depression…
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Adrenaline for the Treatment of No-Reflow in Normotensive Patients [Phase 4]
Phase 4 trial update evaluating adrenaline for treating no-reflow in normotensive patients with acute coronary syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial evaluating the effects and plasma concentration of ticagrelor when crushed vs non-crushed in Acute Coronary Syndrome …
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Early Risk Stratification in ED Chest Pain Patients
A completed clinical trial evaluating early risk stratification in emergency department chest pain patients with acute coronary syndrome; re…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial update for Suxiao Jiuxin Pills in acute coronary syndrome patients with microvascular obstruction.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS) [Phase 4]
Phase 4 trial update evaluating whether a lower dose of aspirin after acute coronary syndrome may be more effective.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention [Phase 2]
Phase 2 safety data for PZ-128 in subjects undergoing non-emergent percutaneous coronary intervention have been posted.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Myocardial Infarction, COmbined-device, Recovery Enhancement Study [NA]
Clinical trial update for a combined-device recovery enhancement study in acute myocardial infarction with completed status and results post…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Role of Alprazolam in the Management of Acute Coronary Syndrome [Phase 1, Phase 2]
Phase 1/2 clinical trial exploring alprazolam for acute coronary syndrome management; status is unknown based on available data.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome [Phase 4]
A Phase 4 clinical trial evaluating the addition of evolocumab to moderate-intensity statin therapy for lowering LDL-C and assessing cardiov…
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Inflammation Reduction by TREhalose AdminisTration [Phase 2]
Phase 2 clinical trial update evaluating trehalose administration for inflammation reduction in acute coronary syndrome.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel [Phase 4]
Phase 4 trial update evaluating reloading prasugrel in patients who previously received a loading dose of clopidogrel in acute coronary synd…
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Early Psychological Intervention to Prevent Cardiovascular Event-Induced PTSD (REACH Sub-study) [NA]
A terminated clinical trial investigating early psychological intervention to prevent PTSD after cardiovascular events; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: OPTImal Management of Antithrombotic Agents: OPTIMA-5 [Phase 4]
Phase 4 clinical trial update for OPTIMA-5 on managing antithrombotic agents in acute coronary syndrome.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome [Phase 4]
Phase 4 trial comparing fixed-dose versus phenotype-based prasugrel dosing in Asians with acute coronary syndrome to match therapeutic windo…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) [Phase 3]
Phase 3 trial update evaluating half-dose prasugrel and ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) completed.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF [Phase 4]
Phase 4 trial comparing apixaban versus phenprocoumon in patients with acute coronary syndrome and atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome [Phase 4]
A Phase 4 clinical trial evaluating ivabradine's effect on inflammatory markers in patients with acute coronary syndromes has completed.